Internet Infinity, Inc. (Japan)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3152880005
JPY
764.00
64 (9.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Company has a low Debt to Equity ratio (avg) at times

 
2

With a growth in Net Profit of 25.89%, the company declared Very Positive results in Dec 25

3

With ROE of 15.58%, it has a very attractive valuation with a 2.24 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 3,789 Million (Micro Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

15.29%

stock-summary
Price to Book

2.33

Revenue and Profits:
Net Sales:
1,489 Million
(Quarterly Results - Dec 2025)
Net Profit:
125 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.24%
0%
22.24%
6 Months
57.2%
0%
57.2%
1 Year
78.09%
0%
78.09%
2 Years
93.42%
0%
93.42%
3 Years
95.4%
0%
95.4%
4 Years
27.55%
0%
27.55%
5 Years
31.95%
0%
31.95%

Internet Infinity, Inc. (Japan) for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.62%
EBIT Growth (5y)
13.11%
EBIT to Interest (avg)
12.37
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
2.04
Tax Ratio
37.55%
Dividend Payout Ratio
25.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.27%
ROE (avg)
9.78%

Valuation key factors

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
2.24
EV to EBIT
7.13
EV to EBITDA
5.12
EV to Capital Employed
3.51
EV to Sales
0.55
PEG Ratio
0.19
Dividend Yield
NA
ROCE (Latest)
49.18%
ROE (Latest)
15.58%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -1.93% vs 6.23% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 25.99% vs 171.70% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,488.60",
          "val2": "1,517.90",
          "chgp": "-1.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "250.80",
          "val2": "199.90",
          "chgp": "25.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.50",
          "val2": "7.90",
          "chgp": "-5.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "124.60",
          "val2": "98.90",
          "chgp": "25.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.80%",
          "val2": "87.40%",
          "chgp": "3.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 4.08% vs 11.08% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 95.33% vs 286.39% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,161.70",
          "val2": "4,959.20",
          "chgp": "4.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "558.40",
          "val2": "399.40",
          "chgp": "39.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.90",
          "val2": "19.90",
          "chgp": "5.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-28.10",
          "chgp": "90.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "255.10",
          "val2": "130.60",
          "chgp": "95.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "77.70%",
          "val2": "46.40%",
          "chgp": "3.13%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
1,488.60
1,517.90
-1.93%
Operating Profit (PBDIT) excl Other Income
250.80
199.90
25.46%
Interest
7.50
7.90
-5.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
124.60
98.90
25.99%
Operating Profit Margin (Excl OI)
121.80%
87.40%
3.44%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -1.93% vs 6.23% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 25.99% vs 171.70% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
5,161.70
4,959.20
4.08%
Operating Profit (PBDIT) excl Other Income
558.40
399.40
39.81%
Interest
20.90
19.90
5.03%
Exceptional Items
-2.80
-28.10
90.04%
Consolidate Net Profit
255.10
130.60
95.33%
Operating Profit Margin (Excl OI)
77.70%
46.40%
3.13%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 4.08% vs 11.08% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 95.33% vs 286.39% in Mar 2024

stock-summaryCompany CV
About Internet Infinity, Inc. (Japan) stock-summary
stock-summary
Internet Infinity, Inc. (Japan)
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available